scispace - formally typeset
Open AccessJournal Article

Long noncoding RNA UCA1 modulates breast cancer cell growth and apoptosis through decreasing tumor suppressive miR-143.

TLDR
UCA1 can directly interact with miR-143, lower its expression and affect its downstream regulation, which constitutes a part of the oncogenic role of UCA1 in breast cancer.
Abstract
Objective Long non coding RNA (LncRNA) urothelial carcinoma-associated 1 (UCA1) is an oncogene in breast cancer. However, the detailed mechanism has not been fully revealed. This study explored whether UCA1 can directly interact with miR-143, a tumor suppressor in breast cancer and whether the UCA1-miR-143 axis is involved in regulation of cancer cell growth and apoptosis. Patients and methods miRNA microarray was performed to identify the most dysregulated miRNAs between tumor and adjacent normal tissues of breast cancer. QRT-PCR analysis was performed to assess the expression of UCA1 and miR-143. The binding between UCA1 and miR-143 was verified using dual luciferase and RNA binding protein immunoprecipitation (RIP) assay. MTT assay and flow cytometry analysis were performed to study the role of UCA1-miR-143 axis in cell proliferation, cell cycle and apoptosis. Results UC1 was significantly upregulated, while miR-143 was significantly downregulated in the tumor tissues than in the adjacent normal tissues. There are direct interactions between miR-143 and the miRNA recognition sites of UCA1. UCA1 is present in Ago2-containing RNA-induced silencing complex (RISC), through association with miR-143. Through downregulating miR-143, UCA1 can modulate breast cancer cell growth and apoptosis. Conclusions UCA1 can directly interact with miR-143, lower its expression and affect its downstream regulation. Therefore, the UCA1-miR-143 axis constitutes a part of the oncogenic role of UCA1 in breast cancer.

read more

Citations
More filters
Journal ArticleDOI

Long Non-Coding RNA in the Pathogenesis of Cancers.

TL;DR: The latest findings regarding the roles and mechanisms of some important lncRNAs in the pathogenesis of certain malignant cancers, including lung, breast, liver, and colorectal cancers, as well as hematological malignancies and neuroblastoma are discussed.
Journal ArticleDOI

Long Noncoding RNAs as Biomarkers in Cancer.

TL;DR: This review focuses on summarizing the perspectives of lncRNAs as biomarkers in cancer, based on evaluating their expression profiles determined in body fluids of cancer patients.
Journal ArticleDOI

LncRNA—UCA1 enhances cell proliferation and 5-fluorouracil resistance in colorectal cancer by inhibiting miR-204-5p

TL;DR: The present work provides the first evidence of a UCA1-miR-204-5p-CREB1/BCL2/RAB22A regulatory network in CRC and reveals that U CA1 and CREB1 are potential new oncogenes and prognostic factors for CRC.
Journal ArticleDOI

Interaction and cross-talk between non-coding RNAs

TL;DR: This review will present and discuss interactions, cross-talk, and co-regulation of ncRNAs and gene regulation due to these interactions.
Journal ArticleDOI

LncRNA UCA1, Upregulated in CRC Biopsies and Downregulated in Serum Exosomes, Controls mRNA Expression by RNA-RNA Interactions.

TL;DR: The UCA1 regulatory axis would represent a promising target to develop innovative RNA-based therapeutics against CRC and functional enrichment analysis of the RNA-RNA network controlled by U CA1 suggested its potential involvement in cellular migration.
Related Papers (5)